Novartis' spending on research and development by segment 2017-2023
This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2023, by business segment. In 2023, the company spent the highest amount within the given period, around 11.4 billion U.S. dollars, for research and development in the brand pharmaceuticals division.